Home › T-Cell Prolymphocytic Leukemia › Texas
T-Cell Prolymphocytic Leukemia clinical trials in Texas
4 studies for T-Cell Prolymphocytic Leukemia are looking for participants at sites in Texas.
Cities in Texas
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
- The University of Texas M. D. Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07311746A Registry for People With T-cell Lymphoma
- MD Anderson Cancer Center (Data Collection Only), Houston
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 13 and older · All sexes · Updated May 5, 2026 · NCT04771572A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL
- MD Anderson, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT04496349From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.